Group One Trading
TXG icon

Group One Trading’s 10x Genomics TXG Stock Holding History

Group One Trading’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.42M Buy
37,100
+23,900
+181% +$626K ﹤0.01% 2548
2026
Q1 		$280K Sell
13,200
-53,500
-80% -$1.07M ﹤0.01% 3863
2025
Q4 		$1.09M Buy
66,700
+600
+0.9% +$9.06K ﹤0.01% 2809
2025
Q3 		$773K Buy
66,100
+44,800
+210% +$584K ﹤0.01% 3278
2025
Q2 		$247K Sell
21,300
-34,200
-62% -$312K ﹤0.01% 4131
2025
Q1 		$485K Buy
55,500
+38,600
+228% +$487K ﹤0.01% 3115
2024
Q4 		$243K Buy
16,900
+9,600
+132% +$151K ﹤0.01% 3786
2024
Q3 		$165K Sell
7,300
-800
-10% -$16.5K ﹤0.01% 3794
2024
Q2 		$158K Sell
8,100
-50,300
-86% -$1.32M ﹤0.01% 3597
2024
Q1 		$2.19M Sell
58,400
-1,100
-2% -$48.3K 0.01% 1412
2023
Q4 		$3.33M Sell
59,500
-70,400
-54% -$3.06M 0.01% 1440
2023
Q3 		$5.36M Buy
129,900
+94,400
+266% +$4.91M 0.02% 908
2023
Q2 		$1.98M Sell
35,500
-2,700
-7% -$146K 0.01% 1722
2023
Q1 		$2.13M Buy
38,200
+17,800
+87% +$831K 0.01% 1469
2022
Q4 		$743K Buy
20,400
+12,600
+162% +$412K ﹤0.01% 2684
2022
Q3 		$222K Sell
7,800
-18,700
-71% -$712K ﹤0.01% 4040
2022
Q2 		$1.2M Buy
26,500
+11,600
+78% +$602K ﹤0.01% 2571
2022
Q1 		$1.13M Sell
14,900
-19,100
-56% -$1.67M ﹤0.01% 2961
2021
Q4 		$5.07M Buy
34,000
+4,900
+17% +$751K ﹤0.01% 1689
2021
Q3 		$4.24M Buy
29,100
+8,700
+43% +$1.49M ﹤0.01% 1875
2021
Q2 		$4M Sell
20,400
-13,100
-39% -$2.37M ﹤0.01% 1907
2021
Q1 		$6.06M Sell
33,500
-23,400
-41% -$4.04M 0.01% 1349
2020
Q4 		$8.06M Buy
56,900
+17,700
+45% +$2.57M 0.01% 950
2020
Q3 		$4.89M Sell
39,200
-5,400
-12% -$567K 0.02% 931
2020
Q2 		$3.98M Buy
44,600
+43,200
+3,086% +$3.36M 0.02% 967
2020
Q1 		$87K Buy
1,400
+1,300
+1,300% +$101K ﹤0.01% 3398
2019
Q4 		$8K Buy
+100
New +$6.01K ﹤0.01% 4661

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Group One Trading's TXG Position: Q2 2026 in Review

Group One Trading sold out of 10x Genomics (TXG) in Q2 2026, closing a stake of 3,843 shares — an estimated $101K sold.

Group One Trading first reported a position in TXG in Q4 2019 and held it in 11 quarters. The position peaked at $1.31M in Q1 2024. 393 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Group One Trading reported no remaining 10x Genomics position as of Q2 2026 after selling out during the quarter.
  • Group One Trading sold 3,843 10x Genomics shares in Q2 2026, an estimated $101K.
  • Group One Trading first reported a position in 10x Genomics in Q4 2019 and held it in 11 quarters.
  • Group One Trading's 10x Genomics position peaked at $1.31M in Q1 2024.
  • 393 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.